## Abstract We explored the neural substrate of anosognosia for cognitive impairment in Alzheimer's disease (AD). Two hundred nine patients with mild to moderate dementia and their caregivers assessed patients' cognitive impairment by answering a structured questionnaire. Subjects rated 13 cognitiv
Smell identification test as an indicator for cognitive impairment in Alzheimer's disease
✍ Scribed by Y. Suzuki; S. Yamamoto; H. Umegaki; J. Onishi; N. Mogi; H. Fujishiro; A. Iguchi
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 99 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.1161
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Objectives
The aim of the present study was to assess olfactory dysfunction in patients with Alzheimer's disease (AD) and to compare utility of the olfactory tests as possible clinical markers.
Methods
Two olfactory identification tests (The Cross‐Cultural Smell Identification Test [CC‐SIT] and the Picture‐based Smell Identification Test [P‐SIT]) and the Mini Mental State Examination (MMSE) were administered to patients with AD and age‐matched controls. Apolipoprotein E (Apo E) genotypes of patients with AD were identified.
Results
Patients with AD had significantly lower olfactory identification scores than age‐matched non‐demented elderly subjects in both olfactory assessments. In the AD group, the coefficient of correlation between the MMSE scores and the P‐SIT scores was higher than that between the MMSE scores and the CC‐SIT scores. Receiver operating curve (ROC) analyses for both tests indicated that the P‐SIT discriminated AD patients from controls more reliably than did the CC‐SIT. Within AD patients, those who were carrying one or two ApoE ε4 alleles had a higher coefficient of correlation between the MMSE scores and the P‐SIT scores than patients without the ApoE ε4 allele.
Conclusions
The results suggest that a short and simple non‐lexical olfactory identification test can be useful as a clinical marker of AD appropriate for Japanese elderly population. Copyright © 2004 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract ## Aims Several studies have shown that Alzheimer's disease (AD) is associated with hyposmia. Olfactory identification may be a cheap and simple additional test in the assessment of early cognitive changes. The sense of smell is influenced by factors such as experience and culture and
## Abstract ## Objectives To investigate the correlation between anosognosia and behavioural symptoms, performance on executive tests, and frontal cortex regional cerebral blood flow (rCBF) in patients with ‘amnestic mild cognitive impairment’ (MCI) and mild Alzheimer's disease (AD). ## Methods
## Abstract ## Objective to investigate patterns of anosognosia for memory deficit in subjects with amnestic mild cognitive impairment (MCI) and Alzheimer's disease (AD). ## Methods the study involved twenty‐five subjects with MCI, 15 with mild AD and 21 normal controls (NC). Subjective rating o
## Abstract ## Objective This study was set up to investigate whether neuropsychological tests are able to predict conversion to AD among Mild Cognitive Impairment (MCI) patients. ## Methods At baseline the cognitive part of the Cambridge Examination for Mental Disorders of the Elderly (CAMCOG),
## Abstract Cognitive impairment is common in Parkinson's disease (PD) and can occur early in the disease course. No effective screening test exists for detection of early or mild cognitive impairment in PD. We examined the Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive dysf